Call us on+91-7490041245
Get a Quote
EnglishSpanishPortugueseFrench

Sofosbuvir Tablets Manufacturer and Supplier for Global Hepatitis Treatment Markets

The global fight against Hepatitis C has transformed significantly over the past decade, with direct-acting antiviral (DAA) medicines offering higher cure rates, shorter treatment durations, and improved patient outcomes. Among these breakthrough therapies, Sofosbuvir Tablets have become one of the most widely prescribed antiviral medicines for Hepatitis C treatment. As healthcare systems expand access to affordable antiviral medicines, pharmaceutical companies, government procurement agencies, hospitals, NGOs, and international distributors continue to seek dependable Sofosbuvir Tablets Manufacturers capable of delivering high-quality products that comply with international quality standards.

Choosing the right manufacturing partner is critical for pharmaceutical businesses serving regulated and semi-regulated markets. Buyers require consistent product quality, WHO-GMP certified manufacturing, comprehensive regulatory documentation, reliable production capacity, and timely global delivery.

Wellona Pharma is a trusted Sofosbuvir Tablets Manufacturer and Supplier, offering WHO-GMP certified manufacturing, advanced quality assurance systems, contract manufacturing, private labeling, and pharmaceutical exports to more than 86 countries worldwide. Our manufacturing excellence enables global healthcare providers to access high-quality antiviral medicines through reliable supply partnerships.

Understanding Sofosbuvir Tablets

Sofosbuvir is a direct-acting antiviral (DAA) medicine used as part of combination therapy for the treatment of chronic Hepatitis C Virus (HCV) infection. Treatment regimens vary depending on viral genotype, patient condition, and local clinical guidelines. Healthcare professionals prescribe Sofosbuvir in combination with other antiviral medicines to achieve sustained virological response (SVR), commonly referred to as a cure.

Sofosbuvir-based therapy has significantly improved Hepatitis C management due to:

  • High treatment success rates
  • Shorter treatment duration
  • Better patient tolerability
  • Reduced progression to liver cirrhosis
  • Lower risk of liver-related complications

Because of these clinical advantages, Sofosbuvir remains an essential product in antiviral medicine portfolios worldwide.

Wellona Pharma – Trusted WHO-GMP Manufacturer

As a leading pharmaceutical exporter, Wellona Pharma manufactures Sofosbuvir tablets using advanced pharmaceutical technology within WHO-GMP certified manufacturing facilities.

Our Tablet Manufacturing Division is equipped with:

  • Automated tablet compression systems
  • Controlled manufacturing environments
  • Modern coating equipment
  • Advanced quality control laboratories
  • Experienced pharmaceutical professionals
  • High-capacity production lines
  • International packaging facilities
  • Export-focused documentation support

Our facilities are designed to consistently manufacture high-quality antiviral medicines that meet international pharmaceutical standards.

Available Dosage Strengths

We manufacture Sofosbuvir tablets according to international market requirements.

Common strengths include:

  • Sofosbuvir 400 mg Tablets

Customized packaging, labeling, and branding are available depending on country-specific regulatory requirements and customer preferences.

WHO-GMP Manufacturing Excellence

Quality manufacturing is the foundation of successful pharmaceutical exports.

Our WHO-GMP certified manufacturing processes include:

  • Validated manufacturing procedures
  • Controlled environmental conditions
  • Qualified personnel
  • Equipment calibration and validation
  • Batch documentation
  • Product traceability
  • Continuous quality monitoring
  • Compliance with international Good Manufacturing Practices

These systems help ensure every production batch delivers consistent quality and performance.

Sophisticated Manufacturing Process

Every batch of Sofosbuvir tablets undergoes carefully controlled manufacturing stages.

Raw Material Qualification

Only pharmaceutical-grade Active Pharmaceutical Ingredients (API) sourced from approved vendors are accepted after comprehensive quality evaluation.

Laboratory Testing

Incoming raw materials undergo:

  • Identity testing
  • Purity analysis
  • Assay testing
  • Moisture analysis
  • Microbial evaluation

Materials are approved only after meeting strict internal quality standards.

Granulation

Validated granulation techniques ensure:

  • Excellent powder flow
  • Uniform blending
  • Improved compressibility
  • Consistent dosage distribution

Tablet Compression

Modern tablet presses maintain:

  • Uniform tablet weight
  • Accurate dosage
  • Optimal hardness
  • Proper thickness
  • Excellent physical appearance

Film Coating

Film coating improves:

  • Tablet stability
  • Product appearance
  • Patient convenience
  • Protection from environmental exposure

Packaging

Finished tablets are packed under GMP-controlled conditions using automated packaging systems.

Comprehensive Quality Assurance

Every production batch undergoes extensive quality testing before commercial release.

Testing includes:

  • Assay
  • Dissolution
  • Identification
  • Disintegration
  • Uniformity of dosage units
  • Hardness
  • Friability
  • Stability studies
  • Microbiological testing

Quality assurance personnel review complete batch documentation before approval.

Learn more about our Quality Control & Quality Assurance systems.

Packaging Solutions

International buyers require different packaging formats depending on market regulations.

Wellona Pharma offers:

  • Alu-Alu blister packs
  • PVC blister packs
  • HDPE bottles
  • Hospital packaging
  • Institutional supply packs
  • Bulk export cartons
  • Private label packaging

Packaging artwork can be customized according to customer branding and local regulatory requirements.

Export Markets

Wellona Pharma exports pharmaceutical products to more than 86 countries, serving:

  • Africa
  • Southeast Asia
  • Middle East
  • CIS Countries
  • Latin America
  • Caribbean
  • Pacific Islands
  • Selected European markets

Our experienced export department manages documentation, logistics coordination, and shipment compliance for international customers.

Regulatory Documentation

Successful pharmaceutical registration requires comprehensive technical documentation.

We provide:

  • Certificate of Pharmaceutical Product (COPP)
  • Certificate of Analysis (COA)
  • Batch Manufacturing Record
  • Stability Data
  • Product Dossier
  • CTD/ACTD Documentation
  • Free Sale Certificate
  • Material Safety Data Sheet (MSDS)
  • Validation Reports

These documents simplify product registration and import procedures in multiple international markets.

Contract Manufacturing and Private Label Services

Many pharmaceutical companies rely on contract manufacturing to expand their product portfolios efficiently.

Our Contract Manufacturing and Third Party Manufacturing services include:

  • WHO-GMP manufacturing
  • Private labeling
  • OEM manufacturing
  • Custom packaging
  • Artwork development
  • Regulatory documentation
  • Export logistics
  • Dedicated project support

These services enable pharmaceutical companies to launch high-quality antiviral products under their own brands.

Why Choose Wellona Pharma?

Global pharmaceutical companies choose Wellona Pharma because we offer:

  • WHO-GMP certified manufacturing
  • Competitive international pricing
  • Large-scale manufacturing capacity
  • Reliable production scheduling
  • Consistent batch quality
  • Comprehensive regulatory support
  • Flexible packaging solutions
  • Experienced export management
  • Long-term business partnerships
  • Dedicated customer service

Our integrated manufacturing and export capabilities make us a trusted partner for pharmaceutical businesses worldwide.

Growing Global Demand for Hepatitis C Medicines

The global burden of Hepatitis C remains a major public health concern. Governments and healthcare organizations continue investing in screening programs, treatment access, and elimination initiatives.

This increasing demand drives procurement by:

  • Government healthcare agencies
  • National Hepatitis programs
  • International NGOs
  • Hospital procurement departments
  • Pharmaceutical distributors
  • Specialty pharmacies
  • Healthcare institutions

Reliable manufacturers capable of maintaining uninterrupted production are essential to support these global healthcare initiatives.

For additional information regarding Hepatitis C management, visit the World Health Organization – Hepatitis C.

International Supply Chain Excellence

Supplying antiviral medicines globally requires more than manufacturing expertise.

Our international supply chain includes:

  • Forecast-based production planning
  • Efficient inventory management
  • Export-compliant packaging
  • Regulatory documentation support
  • Logistics coordination
  • Timely shipment scheduling
  • Customer communication throughout the supply process

This integrated approach enables uninterrupted medicine availability for customers across multiple international markets.

Long-Term Pharmaceutical Partnership

At Wellona Pharma, we believe successful pharmaceutical partnerships are built on trust, transparency, and consistent performance.

We work closely with:

  • Pharmaceutical importers
  • Government procurement agencies
  • Hospital purchasing organizations
  • International distributors
  • Healthcare NGOs
  • Private pharmaceutical brands

By combining advanced manufacturing with export expertise, we help customers strengthen their market presence while ensuring dependable medicine supply.

Frequently Asked Questions (FAQs)

1. Does Wellona Pharma manufacture Sofosbuvir 400 mg tablets?

Yes. We manufacture Sofosbuvir 400 mg tablets according to international quality standards and customer requirements.

2. Are your Sofosbuvir tablets manufactured in WHO-GMP certified facilities?

Yes. Our production facilities follow WHO-GMP guidelines with validated manufacturing processes and stringent quality control systems.

3. Do you provide private label manufacturing?

Yes. We offer OEM manufacturing, private labeling, customized packaging, and branding solutions for pharmaceutical companies worldwide.

4. Which countries do you export Sofosbuvir tablets to?

We export pharmaceutical products to more than 86 countries across Africa, Asia, the Middle East, CIS nations, Latin America, and other international markets.

5. What regulatory documents accompany exports?

We provide COA, COPP, CTD/ACTD dossiers, stability studies, Free Sale Certificates, Batch Manufacturing Records, MSDS, and other registration documents required by importing countries.

Partner with Wellona Pharma for WHO-GMP Sofosbuvir Tablet Manufacturing

If your organization is searching for a reliable Sofosbuvir Tablets Manufacturer and Supplier with WHO-GMP certified facilities, international export experience, and comprehensive regulatory support, Wellona Pharma is your trusted pharmaceutical manufacturing partner.

Visit our Tablet Product Category to explore our complete range of tablet formulations, or contact our team today to discuss bulk procurement, contract manufacturing, third-party manufacturing, private labeling, and global pharmaceutical export opportunities.